TELA Bio Sees Q2 Sales $20.000M vs $21.043M Est

Benzinga Newsdesk www.benzinga.com Positive 77.4%

Neg 0% Neu 0% Pos 77.4%

TELA Bio (NASDAQ:TELA) sees Q2 sales of $20.000 million vs $21.043 million analyst estimate.

Comments

No comments yet. Be the first!